(Q36640326)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Delivery systems and adjuvants for oral vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

D T O'Hagan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

747-762

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17076597%20AND%20SRC:MED&resulttype=core&format=json

Vaccines: past, present and future

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Generation of improved mucosal vaccines by induction of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Collaboration of epithelial cells with organized mucosal lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

NALT- versus Peyer's-patch-mediated mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Regulation of IgA synthesis at mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches--a personal and historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Use of fluorescence imaging to investigate the structure and function of intestinal M cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Is an improved measles-mumps-rubella vaccine necessary or feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Enteric pathogens as vaccine vectors for foreign antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Microparticles as vaccine adjuvants and delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

A month-long effect from a single injection of microencapsulated human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Oral immunization with influenza virus in biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Protection against vaginal SIV transmission with microencapsulated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Novel approaches to pediatric vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Enhancement of rotavirus immunogenicity by microencapsulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

The efficacy of oral vaccination of mice with alginate encapsulated outer membrane proteins of Pasteurella haemolytica and One-Shot

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Biologically erodable microspheres as potential oral drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Oral immunization with enterocoated microbeads induces antigen-specific cytolytic T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Transit of pharmaceutical dosage forms through the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Absorption Enhancers for Nasal Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Current status and potential application of ISCOMs in veterinary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

DNA vaccines: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

A method for oral DNA delivery with N-acetylated chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Triggering TLR signaling in vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Lectins as plant defense proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Immunological implications of the use of plant lectins for drug and vaccine targeting to the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

The potential use of receptor-mediated endocytosis for oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Adhesins and invasins of pathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Discrimination Between Intracellular Uptake and Surface Adhesion of Bacterial Pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capability to L929 cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Endogenous lectins as targets for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Plant cell factories and mucosal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Immunogenicity in humans of an edible vaccine for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Progress on new vaccine strategies against chronic viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Specific antigen vaccination to treat autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Vaccines for mucosal immunity to combat emerging infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747

A protein secreted by Trypanosoma cruzi capable of inducing the entry of inert particles into HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.6.747